Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Amyloid × Head & Neck × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 1

Interventions

pembrolizumab 57 Cisplatin 46 Radiotherapy, Intensity-Modulated 26 Nivolumab 24 Carboplatin 22 Paclitaxel 17 Radiotherapy 15 Cetuximab 14 Radiation 13 Magnetic Resonance Spectroscopy 13 Gemcitabine 13 Docetaxel 13 durvalumab 11 Fluorouracil 9 Taxes 8 Surveys and Questionnaires 8 Specimen Handling 8 Platinum 8 Drug Therapy 7 Capecitabine 7 Biopsy 7 1,2-diaminocyclohexaneplatinum II citrate 7 trametinib 6 Bevacizumab 6 tislelizumab 5 fludarabine 5 cabozantinib 5 avelumab 5 atezolizumab 5 Ipilimumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05997329 2025-09-08

NUTREAT

University of Oslo

Phase NA Active not recruiting

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡